SOBEN Pharma Station: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SOBEN Pharma Station
Largest movements
- Receivables after one year +€243,620
up €243,620 (+230%), from €105,891 to €349,511
- Receivables within one year +€122,556
up €122,556 (+211%), from €58,042 to €180,598
of which Trade receivables: +€122,556
- Cash +€25,279
up €25,279 (+349%), from €7,237 to €32,516
mainly Trade debts (+€111,498) and Short-term financial debts (+€81,924)
- Trade debts +€111,498
up €111,498 (+152%), from €73,402 to €184,901
- Short-term financial debts +€81,924
up €81,924 (+102%), from €80,000 to €161,924
- Debts after one year +€74,610
up €74,610 (+98.9%), from €75,414 to €150,023
- Other debts +€74,000
up €74,000 (+370%), from €20,000 to €94,000
- Current portion of long-term debt +€23,903
up €23,903 (+105%), from €22,672 to €46,575
- Gross operating margin +€91,184
up €91,184 (+52.4%), from €173,852 to €265,036
- Staff costs +€26,605
up €26,605 (+21.5%), from €123,855 to €150,461
- Taxes +€17,729
up €17,729 (+204%), from €8,701 to €26,430
- Financial charges -€3,219
down €3,219 (-17.2%), from €18,758 to €15,539
- Financial income +€3,057
up €3,057 (+69.5%), from €4,396 to €7,453
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €339,940 | €732,996 | +€393,056 | +116% |
| Fixed assets | 21/28 | €46,817 | €41,478 | -€5,340 | -11.4% |
| Tangible fixed assets | 22/27 | €46,817 | €41,478 | -€5,340 | -11.4% |
| Furniture and vehicles | 24 | €8,650 | €6,864 | -€1,786 | -20.6% |
| Other tangible fixed assets | 26 | €38,168 | €34,614 | -€3,554 | -9.3% |
| Current assets | 29/58 | €293,122 | €691,518 | +€398,396 | +136% |
| Amounts receivable after more than one year | 29 | €105,891 | €349,511 | +€243,620 | +230% |
| Other amounts receivable | 291 | €105,891 | €349,511 | +€243,620 | +230% |
| Stocks and contracts in progress | 3 | €120,243 | €127,169 | +€6,926 | +5.8% |
| Stocks | 30/36 | €120,243 | €127,169 | +€6,926 | +5.8% |
| Amounts receivable within one year | 40/41 | €58,042 | €180,598 | +€122,556 | +211% |
| Trade receivables | 40 | €58,042 | €180,598 | +€122,556 | +211% |
| Other amounts receivable | 41 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €7,237 | €32,516 | +€25,279 | +349% |
| Deferred charges and accrued income | 490/1 | €1,710 | €1,725 | +€15 | +0.9% |
| Total equity and liabilities | 10/49 | €339,940 | €732,996 | +€393,056 | +116% |
| Equity | 10/15 | €38,243 | €42,294 | +€4,051 | +10.6% |
| Contributions | 10/11 | €20,500 | €20,500 | = | 0.0% |
| Reserves | 13 | €17,743 | €21,794 | +€4,051 | +22.8% |
| Distributable reserves | 133 | €17,743 | €21,794 | +€4,051 | +22.8% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €301,697 | €690,702 | +€389,005 | +129% |
| Amounts payable after more than one year | 17 | €75,414 | €150,023 | +€74,610 | +98.9% |
| Financial debts | 170/4 | €75,414 | €150,023 | +€74,610 | +98.9% |
| Amounts payable within one year | 42/48 | €224,605 | €539,522 | +€314,917 | +140% |
| Current portion of amounts payable after more than one year | 42 | €22,672 | €46,575 | +€23,903 | +105% |
| Financial debts | 43 | €80,000 | €161,924 | +€81,924 | +102% |
| Credit institutions | 430/8 | €80,000 | €161,924 | +€81,924 | +102% |
| Trade debts | 44 | €73,402 | €184,901 | +€111,498 | +152% |
| Suppliers | 440/4 | €73,402 | €184,901 | +€111,498 | +152% |
| Taxes, remuneration and social security | 45 | €28,530 | €52,122 | +€23,592 | +82.7% |
| Taxes | 450/3 | €9,188 | €22,267 | +€13,079 | +142% |
| Remuneration and social security | 454/9 | €19,342 | €29,855 | +€10,513 | +54.4% |
| Other amounts payable | 47/48 | €20,000 | €94,000 | +€74,000 | +370% |
| Accrued charges and deferred income | 492/3 | €1,678 | €1,156 | -€522 | -31.1% |
| Remuneration, social security and pensions | 62 | €123,855 | €150,461 | +€26,605 | +21.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,624 | €5,340 | -€284 | -5.1% |
| Other operating charges | 640/8 | €478 | €669 | +€190 | +39.7% |
| Gross operating margin | 9900 | €173,852 | €265,036 | +€91,184 | +52.4% |
| Operating profit (loss) | 9901 | €43,895 | €108,567 | +€64,672 | +147% |
| Financial income | 75/76B | €4,396 | €7,453 | +€3,057 | +69.5% |
| Recurring financial income | 75 | €4,396 | €7,453 | +€3,057 | +69.5% |
| Financial charges | 65/66B | €18,758 | €15,539 | -€3,219 | -17.2% |
| Recurring financial charges | 65 | €18,758 | €15,539 | -€3,219 | -17.2% |
| Profit (loss) for the period before taxes | 9903 | €29,532 | €100,481 | +€70,949 | +240% |
| Income taxes | 67/77 | €8,701 | €26,430 | +€17,729 | +204% |
| Profit (loss) for the period | 9904 | €20,832 | €74,051 | +€53,220 | +255% |
| Profit (loss) for the period to be appropriated | 9905 | €20,832 | €74,051 | +€53,220 | +255% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.